Pivotal European Study Results Show Innovative Cancer Diagnostic Technology
By MedImaging International staff writers Posted on 27 Dec 2016 |
Image: The diagram describes the principle of the photoacoustic effect and imaging used in the SENO Medical Imagio modality (Photo courtesy of Ultrasonography).
A medical imaging company that pioneered a novel opto-acoustic breast-imaging technology has released new down-classification and up-classification data from a European post-market surveillance and clinical follow-up study called MAESTRO.
The final results of the MAESTRO study are expected to be released in early 2017, while the results from another large-scale trial of the technology in the US called PIONEER that includes more than 2,000 patients are planned to be released in the second half of 2017.
Seno Medical Instruments (San Antonia, TX, USA) is developing and commercializing the Imagio opto-acoustic breast-cancer diagnostics imaging modality. The solution combines results from the Imagio system with ultrasound scans to produce functional and anatomical images of the breast, including a color map for suspicious breast masses, with standard anatomic ultrasound images. The new modality could help radiologists confirm or rule out malignancy in breast tumors without the use of ionizing radiation or contrast agents.
Medical Director of SENO Medical, Thomas Stavros, MD, said, "The Imagio breast imaging system represents a significant advance to improve the diagnoses of breast cancer by helping to determine the appropriate classification of breast masses. The presentation of the histological data will be of particular interest to the oncology community as it will identify a correlation between the opto-acoustic imaging findings and histologic grade of the breast masses."
Related Links:
Seno Medical Instruments
The final results of the MAESTRO study are expected to be released in early 2017, while the results from another large-scale trial of the technology in the US called PIONEER that includes more than 2,000 patients are planned to be released in the second half of 2017.
Seno Medical Instruments (San Antonia, TX, USA) is developing and commercializing the Imagio opto-acoustic breast-cancer diagnostics imaging modality. The solution combines results from the Imagio system with ultrasound scans to produce functional and anatomical images of the breast, including a color map for suspicious breast masses, with standard anatomic ultrasound images. The new modality could help radiologists confirm or rule out malignancy in breast tumors without the use of ionizing radiation or contrast agents.
Medical Director of SENO Medical, Thomas Stavros, MD, said, "The Imagio breast imaging system represents a significant advance to improve the diagnoses of breast cancer by helping to determine the appropriate classification of breast masses. The presentation of the histological data will be of particular interest to the oncology community as it will identify a correlation between the opto-acoustic imaging findings and histologic grade of the breast masses."
Related Links:
Seno Medical Instruments
Latest Ultrasound News
- Groundbreaking Technology Enables Precise, Automatic Measurement of Peripheral Blood Vessels
- Deep Learning Advances Super-Resolution Ultrasound Imaging
- Novel Ultrasound-Launched Targeted Nanoparticle Eliminates Biofilm and Bacterial Infection
- AI-Guided Ultrasound System Enables Rapid Assessments of DVT
- Focused Ultrasound Technique Gets Quality Assurance Protocol
- AI-Guided Handheld Ultrasound System Helps Capture Diagnostic-Quality Cardiac Images
- Non-Invasive Ultrasound Imaging Device Diagnoses Risk of Chronic Kidney Disease
- Wearable Ultrasound Platform Paves Way for 24/7 Blood Pressure Monitoring On the Wrist
- Diagnostic Ultrasound Enhancing Agent to Improve Image Quality in Pediatric Heart Patients
- AI Detects COVID-19 in Lung Ultrasound Images
- New Ultrasound Technology to Revolutionize Respiratory Disease Diagnoses
- Dynamic Contrast-Enhanced Ultrasound Highly Useful For Interventions
- Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis
- Artificial Intelligence Detects Heart Defects in Newborns from Ultrasound Images
- Ultrasound Imaging Technology Allows Doctors to Watch Spinal Cord Activity during Surgery
- Shape-Shifting Ultrasound Stickers Detect Post-Surgical Complications